Surgical treatment of nonpalpable primary invasive and in situ breast cancer-Reference-Cited by-同舟云学术

Surgical treatment of nonpalpable primary invasive and in situ breast cancer

Published:2015-09-29 Issue:11 Volume:12 Page:645-663
ISSN:1759-4774
Container-title:Nature Reviews Clinical Oncology
language:en
Short-container-title:Nat Rev Clin Oncol

Author:

Ahmed Muneer,Rubio Isabel T.,Klaase Joost M.,Douek Michael

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://www.nature.com/articles/nrclinonc.2015.161.pdf

Reference158 articles.

1. ISD Scotland. Cancer Incidence in Scotland (2011) [online] , (2013).

2. Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales. Cancer in Wales [online] , (2015).

3. Office for National Statistics. Cancer Statistics Registrations, England (Series MB1), No. 44, 2013 [online] , (2015).

4. Northern Ireland Cancer Registry. Breast [online] , (2015).

5. Westlake, S. & Cooper, N. Cancer incidence and mortality: trends in the United Kingdom and constituent countries, 1993 to 2004. Health Stat. Q. 2008, 33–46 (2008).

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful excision of non–palpable breast lesions using a magnetic surgical marker navigation system in a specialized French oncologic center;2024-06-25

2. A homogeneous electrochemical sensing platform based on DNAzyme walker for accurate detection of breast cancer exosomes;Sensors and Actuators B: Chemical;2024-04

3. Mammographically detected breast clustered microcalcifications localized by chest thin-section computed tomography;World Journal of Surgical Oncology;2024-02-29

4. Contribution of preoperative ultrasound-guided implantation of a magnetic seed for optimal localization and resection of vulvar angiosarcoma: A case report;International Journal of Surgery Case Reports;2024-01

5. European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO;European Journal of Surgical Oncology;2024-01